SCHEMBL3398976

SCHEMBL3398976

CC(C)(C)Cc1c[nH]c2ncc(-c3cccc(-c4ccn[nH]4)c3)nc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 9/20 0.49
PDPK1 O15530 1/20 0.39
CLK1 P49759 1/20 0.38
CLK2 P49760 1/20 0.38
CLK3 P49761 1/20 0.38
DYRK1A Q13627 1/20 0.38
HIPK1 Q86Z02 1/20 0.38
HIPK2 Q9H2X6 1/20 0.38
HIPK3 Q9H422 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
DYRK1B Q9Y463 1/20 0.38
NOTUM Q6P988 1/20 0.38
CD74 P04233 1/20 0.38
MIF P14174 1/20 0.38
CYP2E1 P05181 1/20 0.36
CYP2A6 P11509 1/20 0.36
CYP2B6 P20813 1/20 0.36
CYP2D6 P10635 1/20 0.36
SYK P43405 1/20 0.36
EGFR P00533 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3396005 0.84 SCN9A (0.42) MAPK1CYP2E1CYP2A6CYP2B6CYP2D6
SCHEMBL2280067 0.79 JAK3 (0.56) MAPK1CD74MIFCYP2D6SYK
SCHEMBL3399095 0.78 CDK8 (0.42) MAPK1CLK1DYRK1ACYP2D6SYK
SCHEMBL3396270 0.77 CDK8 (0.48) MAPK1CLK1DYRK1ACYP2D6SYK
SCHEMBL3393845 0.77 MAPK1 (0.38) MAPK1CLK1DYRK1ACYP2D6SYK
SCHEMBL3396373 0.74 JAK3 (0.44) MAPK1JAK3
SCHEMBL3397956 0.73 MAPK1 (0.42) MAPK1CYP2D6
SCHEMBL3394716 0.72 CYP2D6 (0.35) MAPK1CYP2D6SYKJAK3
SCHEMBL2337979 0.72 MAPK1 (0.37) MAPK1PDPK1CLK2DYRK1ACLK4
SCHEMBL2341240 0.71 LRRK2 (0.38) MAPK1SYKJAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2245033-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2010-11-03 EP claimed
WO-2009106441-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-09-03 WO claimed